Jiangsu Aoyang Health Industry Co.ltd.

CN¥ 4.06

Last Updated 16.10.2025

Issuer Rating

3/7

Performance

Modest

Risk

Moderate

Recommendation

Sell

Market Cap

CN¥ 436.49M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks

CN¥ 4.06

Key Takeaways

Risk factor

Meaningful price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Jiangsu Aoyang Health Industry Co.ltd. produces and sells chemical fibers in China and internationally. It offers various functional fibers, as well as conventional viscose fibers. The company also operates hospitals, rehabilitation centers, and pharmaceutical retail chains. In addition, it offers health management and pharmaceutical logistics, as well as distributes pharmaceutical products. The company was formerly...

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of 002172.SZ is 5.1 and suggests 26% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks